Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1995 Oct;115(2):289–298. doi: 10.1017/s0950268800058416

Poliomyelitis in The Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992.

H C Rümke 1, P M Oostvogel 1, G Van Steenis 1, A M Van Loon 1
PMCID: PMC2271413  PMID: 7589268

Abstract

An overview of serological and virological studies on poliomyelitis in the Netherlands between two epidemics in 1978 and 1992 is given. Three unvaccinated patients acquired poliomyelitis abroad. In the Netherlands vaccination coverage with quadruple DPT-IPV vaccine is very high. The strong immunogenicity of inactivated poliovirus vaccine was confirmed in a cohort of children, reflected in age-stratified antibody profiles of the population. Adults born in the pre vaccination era appeared in general protected, but 10-25% of persons born between 1930 and 1945 lacked neutralizing antibodies. Revaccination induced a booster type of antibody response in 75-90% of such persons, indicating immunological memory and protection. Virological studies on adopted children from other countries, patients with indications for viral examination, and river waters showed that the Netherlands was regularly exposed to polio virus (PV), without signs of indigenous transmission. Persons found to carry PV or their close contacts had travelled to a PV endemic country. Most of 557 isolates were vaccine-derived, only 8% were wild type viruses. Despite their presence, up to 1992 the well-known susceptibles for PV in the Netherlands were shielded by the herd immunity of the Dutch population.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benyesh-Melnick M., Melnick J. L., Rawls W. E., Wimberly I., Oro J. B., Ben-Porath E., Rennick V. Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol. 1967 Jul;86(1):112–136. doi: 10.1093/oxfordjournals.aje.a120717. [DOI] [PubMed] [Google Scholar]
  2. Bijkerk H. Surveillance and control of poliomyelitis in The Netherlands. Rev Infect Dis. 1984 May-Jun;6 (Suppl 2):S451–S456. doi: 10.1093/clinids/6.supplement_2.s451. [DOI] [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) Poliomyelitis--Netherlands, 1992. MMWR Morb Mortal Wkly Rep. 1992 Oct 16;41(41):775–778. [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Isolation of wild poliovirus type 3 among members of a religious community objecting to vaccination--Alberta, Canada, 1993. MMWR Morb Mortal Wkly Rep. 1993 May 7;42(17):337–339. [PubMed] [Google Scholar]
  5. Conyn-van Spaendonck M. A., Hannik C. A., Bijkerk H., van Noorle Jansen L. M., Plantinga A. D., van Steenis G., van Wezel A. L., Ruitenberg E. J. Immuunstatus in 1980 van de Nederlandse bevolking vanaf 10 jaar tegen poliomyelitis, rubella en morbilli; een serologisch onderzoek. Ned Tijdschr Geneeskd. 1984 Oct 6;128(40):1884–1887. [PubMed] [Google Scholar]
  6. DICK G. W., DANE D. S., McALISTER J., BRIGGS M., NELSON R., FIELD C. M. Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion. Br Med J. 1961 Jul 29;2(5247):266–269. doi: 10.1136/bmj.2.5247.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deming M. S., Jaiteh K. O., Otten M. W., Jr, Flagg E. W., Jallow M., Cham M., Brogan D., N'jie H. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine. Am J Epidemiol. 1992 Feb 15;135(4):393–408. doi: 10.1093/oxfordjournals.aje.a116300. [DOI] [PubMed] [Google Scholar]
  8. Furesz J., Armstrong R. E., Contreras G. Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. Lancet. 1978 Dec 9;2(8102):1248–1248. doi: 10.1016/s0140-6736(78)92113-x. [DOI] [PubMed] [Google Scholar]
  9. Glezen W. P., Lamb G. A., Belden E. A., Chin T. D. Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. Am J Epidemiol. 1966 Mar;83(2):224–237. doi: 10.1093/oxfordjournals.aje.a120578. [DOI] [PubMed] [Google Scholar]
  10. HOWE H. A. The quantitation of poliomyelitis virus in the human alimentary tract with reference to coexisting levels of homologous serum neutralizing antibody. Am J Hyg. 1962 Jan;75:1–17. doi: 10.1093/oxfordjournals.aje.a120227. [DOI] [PubMed] [Google Scholar]
  11. Hofman B. Poliomyelitis in the Netherlands 1958-69: the influence of a vaccination programme with inactivated poliovaccine. Bull World Health Organ. 1972;46(6):735–745. [PMC free article] [PubMed] [Google Scholar]
  12. Hull H. F., Ward N. A., Hull B. P., Milstien J. B., de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet. 1994 May 28;343(8909):1331–1337. doi: 10.1016/s0140-6736(94)92472-4. [DOI] [PubMed] [Google Scholar]
  13. Kim-Farley R. J., Rutherford G., Lichfield P., Hsu S. T., Orenstein W. A., Schonberger L. B., Bart K. J., Lui K. J., Lin C. C. Outbreak of paralytic poliomyelitis, Taiwan. Lancet. 1984 Dec 8;2(8415):1322–1324. doi: 10.1016/s0140-6736(84)90831-6. [DOI] [PubMed] [Google Scholar]
  14. MARINE W. M., CHIN T. D., GRAVELLE C. R. Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic. Am J Hyg. 1962 Sep;76:173–195. doi: 10.1093/oxfordjournals.aje.a120272. [DOI] [PubMed] [Google Scholar]
  15. Moriniere B. J., van Loon F. P., Rhodes P. H., Klein-Zabban M. L., Frank-Senat B., Herrington J. E., Pallansch M. A., Patriarca P. A. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet. 1993 Jun 19;341(8860):1545–1550. doi: 10.1016/0140-6736(93)90693-b. [DOI] [PubMed] [Google Scholar]
  16. Onorato I. M., Modlin J. F., McBean A. M., Thoms M. L., Losonsky G. A., Bernier R. H. Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines. J Infect Dis. 1991 Jan;163(1):1–6. doi: 10.1093/infdis/163.1.1. [DOI] [PubMed] [Google Scholar]
  17. Oostvogel P. M., van Wijngaarden J. K., van der Avoort H. G., Mulders M. N., Conyn-van Spaendonck M. A., Rümke H. C., van Steenis G., van Loon A. M. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. 1994 Sep 3;344(8923):665–670. doi: 10.1016/s0140-6736(94)92091-5. [DOI] [PubMed] [Google Scholar]
  18. Oostvogel P. M., van der Avoort H. G., Mulders M. N., Rümke H. C., van Steenis G., van Loon A. M. Virologische en serologische aspecten van de Nederlandse polio-epidemie in 1992. Ned Tijdschr Geneeskd. 1993 Jul 10;137(28):1404–1406. [PubMed] [Google Scholar]
  19. Patriarca P. A., Foege W. H., Swartz T. A. Progress in polio eradication. Lancet. 1993 Dec 11;342(8885):1461–1464. doi: 10.1016/0140-6736(93)92936-n. [DOI] [PubMed] [Google Scholar]
  20. Schaap G. J., Bijkerk H., Coutinho R. A., Kapsenberg J. G., van Wezel A. L. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic. Prog Med Virol. 1984;29:124–140. [PubMed] [Google Scholar]
  21. Sutter R. W., Patriarca P. A., Brogan S., Malankar P. G., Pallansch M. A., Kew O. M., Bass A. G., Cochi S. L., Alexander J. P., Hall D. B. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet. 1991 Sep 21;338(8769):715–720. doi: 10.1016/0140-6736(91)91442-w. [DOI] [PubMed] [Google Scholar]
  22. Welp E. A., van Steenbergen J. E., Rümke H. C., van Steenis G. Beschermingsgraad tegen poliomyelitis van Nederlanders geboren vór 1945 en van allochtonen in de stad Utrecht, en het verband met de sociaal-economische status. Ned Tijdschr Geneeskd. 1993 Jul 10;137(28):1388–1391. [PubMed] [Google Scholar]
  23. Wright P. F., Kim-Farley R. J., de Quadros C. A., Robertson S. E., Scott R. M., Ward N. A., Henderson R. H. Strategies for the global eradication of poliomyelitis by the year 2000. N Engl J Med. 1991 Dec 19;325(25):1774–1779. doi: 10.1056/NEJM199112193252504. [DOI] [PubMed] [Google Scholar]
  24. van Olphen M., Kapsenberg J. G., van de Baan E., Kroon W. A. Removal of enteric viruses from surface water at eight waterworks in The Netherlands. Appl Environ Microbiol. 1984 May;47(5):927–932. doi: 10.1128/aem.47.5.927-932.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. van Wezel A. L., van Steenis G., Hannik C. A., Cohen H. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand. 1978;41:159–168. [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES